Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived

Po-Hsun Huang1, Yung-Hsiang Chen, Chao-Hung Wang

  • 1Division of Cardiology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan.

Abstract

Insights

Matrix metalloproteinase-9 (MMP-9) deficiency impairs blood flow recovery after ischemia by hindering endothelial progenitor cell (EPC) function. This study reveals MMP-9 is crucial for EPC mobilization and vasculogenesis, essential for neovascularization.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Molecular Biology

Background:

  • Neovascularization is critical for tissue repair following ischemic events.
  • Matrix metalloproteinases (MMPs) and endothelial progenitor cells (EPCs) play key roles in blood vessel formation.
  • MMP-9's specific role in EPC function and neovascularization remains to be fully elucidated.

Purpose of the Study:

  • To investigate the impact of MMP-9 deficiency on EPC function and neovascularization in a mouse model of hindlimb ischemia.
  • To determine the mechanisms by which MMP-9 influences EPC mobilization and vasculogenesis.

Main Methods:

  • Hindlimb ischemia surgery was performed on MMP-9 knockout (MMP-9(-/-)) and wild-type (MMP-9(+/+)) mice.
  • Blood flow recovery was assessed using laser Doppler imaging.
  • Flow cytometry analyzed EPC-like cell populations (Sca-1(+)/Flk-1(+)) and C-kit positive bone marrow cells.
  • Plasma and bone marrow levels of soluble Kit-ligand (sKitL) were measured.
  • In vitro studies assessed EPC colony formation, migration, and tube formation with and without MMP-9 inhibition.
  • Bone marrow transplantation was performed to evaluate functional restoration.

Main Results:

  • MMP-9(-/-) mice exhibited significantly impaired blood flow recovery compared to wild-type mice.
  • Ischemia failed to increase EPC-like cell numbers and sKitL levels in MMP-9(-/-) mice.
  • MMP-9 deficiency attenuated the adhesion and migration of C-kit positive bone marrow cells.
  • In vitro, MMP-9 inhibition suppressed EPC colony formation, migration, and tube formation.
  • Transplantation of wild-type bone marrow cells restored collateral flow in MMP-9(-/-) mice.

Conclusions:

  • MMP-9 deficiency impairs ischemia-induced neovascularization.
  • These effects are mediated by reduced stem cell-active cytokine release, leading to impaired EPC mobilization, migration, and vasculogenesis.
  • MMP-9 is essential for effective EPC function and neovascularization in response to ischemic injury.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...